Healthy adult
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects who are aware of thinning hair and can see through the scalp
Exclusion criteria
Exclusion criteria: 1. Factors that may affect the results of the test at the evaluation region (disease such as atopic dermatitis and urticaria, inflammation, eczema, trauma, acne, pimples, warts, stains, etc., or traces thereof) 2. Subjects who have received aesthetic medicine (hair transplantation, etc.) or AGA treatment at the evaluation region, or who plan to receive it during the test period 3. Subjects who regularly use medicines, quasi-drugs, cosmetics, health foods, and supplements that claim to have a hair-growth effect. 4. Subjects who have been exposed to UV rays beyond their daily lives, such as long hours of outdoor work, exercise, swimming, leisure, etc. within the past 4 weeks, or who plan to do so during the test period. 5. Subjects who work night shifts and shift work day and night 6. At the time of obtaining consent, it is judged that the subjects is receiving treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at a medical institution for the treatment or prevention of the disease, or that treatment is necessary. 7. Subjects who have a history of serious or mental illness of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory organs, respiratory organs, endocrine system, immune system, nervous system. 8. Excessive smokers * and alcohol addicts ** and subjects with extremely irregular diets 9. Subjects who are at risk of developing allergies to cosmetics and foods (including subjects who have developed skin abnormalities such as rashes on cosmetics within the past year) 10. Subjects who have participated in other human tests (all tests for humans using cosmetics, foods, pharmaceuticals, quasi-drugs, medical devices, etc.) within the past 4 weeks, or are planning to conduct this test. Subjects who plan to participate in other human studies during the period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hair thickness measurement, evaluation of scalp condition | — |
Countries
Japan
Contacts
Japan Clinical Trial Association N.A.